1. Pharmaceutical CGMPs for the 21st Century (2004) A Risk-Based Approach Final Report, http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/Manufacturing/QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM176374.pdf, accessed 17 May 2014
2. Guidance for Industry (2004) PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070305.pdf, accessed 17 May 2014
3. ICH Harmonised Tripartite Guideline (2009) Pharmaceutical Development Q8(R2), http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf, accessed 17 May 2014
4. ICH Harmonised Tripartite Guideline (2005) Quality Risk Management Q9, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf, accessed 17 May 2014
5. ICH Harmonised Tripartite Guideline (2008) Pharmaceutical Quality Systems Q10, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q10/Step4/Q10_Guideline.pdf, accessed 17 May 2014